TY - JOUR
T1 - Salvage radical prostatectomy
AU - Nabavizadeh, Reza
AU - Karnes, R. Jeffrey
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Purpose of reviewSalvage radical prostatectomy (sRP) is underutilized because of fear of historical high rates of peri-operative morbidities. However, there has been significant improvements in complication rates as well as oncologic outcomes in the recent years.Recent findingsComplication rates have significantly declined for both open and robotic approach in the past decade. Rectal injury is now reported around 2%, which is down from 30% in the historic series. Similarly, the current risk of major vascular injury is low. About 75% of patients report social continence (up to one pad per day). However, erectile function recovery remains poor and patients should be counselled accordingly. Long-term durable oncologic response is achievable with 10-year recurrence-free survival reported in about 40-50% of well selected patients.SummaryRecent improvements in oncologic and peri-operative outcomes make sRP a desirable option for local control. sRP treats the whole gland as opposed to focal therapies and allows for pelvic lymph node dissection and removal of seminal vesicles, which can be sanctuary site of disease. In experienced hands, regardless of the surgical approach, sRP can achieve a durable response resulting in delaying or avoiding androgen deprivation therapy and its associated morbidities.
AB - Purpose of reviewSalvage radical prostatectomy (sRP) is underutilized because of fear of historical high rates of peri-operative morbidities. However, there has been significant improvements in complication rates as well as oncologic outcomes in the recent years.Recent findingsComplication rates have significantly declined for both open and robotic approach in the past decade. Rectal injury is now reported around 2%, which is down from 30% in the historic series. Similarly, the current risk of major vascular injury is low. About 75% of patients report social continence (up to one pad per day). However, erectile function recovery remains poor and patients should be counselled accordingly. Long-term durable oncologic response is achievable with 10-year recurrence-free survival reported in about 40-50% of well selected patients.SummaryRecent improvements in oncologic and peri-operative outcomes make sRP a desirable option for local control. sRP treats the whole gland as opposed to focal therapies and allows for pelvic lymph node dissection and removal of seminal vesicles, which can be sanctuary site of disease. In experienced hands, regardless of the surgical approach, sRP can achieve a durable response resulting in delaying or avoiding androgen deprivation therapy and its associated morbidities.
KW - oncologic outcomes
KW - postradiation prostatectomy
KW - salvage prostatectomy
KW - surgical complications
UR - http://www.scopus.com/inward/record.url?scp=85147095047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147095047&partnerID=8YFLogxK
U2 - 10.1097/MOU.0000000000001074
DO - 10.1097/MOU.0000000000001074
M3 - Review article
C2 - 36591993
AN - SCOPUS:85147095047
SN - 0963-0643
VL - 33
SP - 163
EP - 167
JO - Current Opinion in Urology
JF - Current Opinion in Urology
IS - 2
ER -